Results 91 to 100 of about 3,310,810 (118)
Some of the next articles are maybe not open access.

Targeted Therapy of CLL

Oncology Research and Treatment, 2016
The landscape of chronic lymphocytic leukemia (CLL) has undergone profound changes in the past years. First, the addition of CD20-targeting antibodies to conventional chemotherapy has improved the therapeutic outcome in the majority of CLL patients.
Othman, Al-Sawaf   +3 more
openaire   +2 more sources

Targeting Targeted Therapy

New England Journal of Medicine, 2004
The emergence of effective cancer chemotherapy is one of the major medical advances of the second half of the 20th century. In certain neoplasms — such as gestational choriocarcinoma, childhood acute lymphoblastic leukemia, and subgroups of Hodgkin's disease and non-Hodgkin's lymphoma — chemotherapy is often curative, and the promise of long-term ...
openaire   +2 more sources

Targeted photodynamic therapy

Lasers in Surgery and Medicine, 2006
AbstractBackground and ObjectivesPhotodynamic therapy (PDT) is an emerging modality for the treatment of various neoplastic and non‐neoplastic pathologies.Study Design/Materials and MethodsPDT usually occurs when reactive oxygen species (ROS) generated from light‐activated chemicals (photosensitizer, PS) destroy the target.
Nicolas, Solban   +2 more
openaire   +2 more sources

A Trial of Targeted Therapy

International Journal of Radiation Oncology*Biology*Physics, 2021
International ...
openaire   +3 more sources

Chemotherapy and Targeted Therapy

2016
Salivary gland cancers are uncommon neoplasms of the head and neck that exhibit considerable pathological, biological, and clinical diversity, resulting in a paucity of prospective data regarding the use of non-surgical treatments. Chemotherapy has shown limited activity in patients with metastatic disease, and there has been little exploration of its ...
Mehmet, Sen, Robin, Prestwich
openaire   +2 more sources

Targeted therapies in melanoma

Cancer Treatment Reviews, 2006
In the last decade the incidence of melanoma has been rising. Despite this, survival remains substantially constant because early diagnosis of thin lesions has increased. By contrast, metastatic melanoma continues to have a poor prognosis and it still represents a challenge for oncologists. Response rates with single agent dacarbazine range from 10% to
Paola, Queirolo, Mirko, Acquati
openaire   +2 more sources

Targeted cancer therapies

Nature Reviews Drug Discovery, 2010
Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies. In 2009, ~16,000 of the ~40,000 Phase I, II and III trials listed on ClinicalTrials.gov were related to cancer (~40%). This large interest stems from the existence of high unmet need for improved treatments of multiple types of cancer and the substantial ...
openaire   +2 more sources

Targeted Therapies in Cancer

BioDrugs, 2010
Recent advances in understanding the biologic mechanisms underlying cancer development have driven the design of new therapeutic approaches, termed 'targeted therapies', that selectively interfere with molecules or pathways involved in tumor growth and progression.
Ciavarella S   +3 more
openaire   +3 more sources

Targeted cancer therapy

Nature, 2004
Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer. Complex networks of regulatory factors, the tumour microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.
openaire   +2 more sources

Targeted Therapies in Mesothelioma

2019
Malignant Pleural Mesothelioma (MPM) is an aggressive disease characterized by chemoresistance and few therapeutic options. First-line platinum-pemetrexed chemotherapy represents the current standard of care, and no indication is available for second-line treatments.
Loredana Urso, Giulia Pasello
openaire   +2 more sources

Home - About - Disclaimer - Privacy